When infection hurts: golden rules for managing pediatric skin and soft tissue infections
- PMID: 40528194
- PMCID: PMC12175349
- DOI: 10.1186/s13052-025-01994-w
When infection hurts: golden rules for managing pediatric skin and soft tissue infections
Abstract
Skin and Soft Tissue Infections (SSTIs) are common in pediatric patients, accounting for nearly 25% of clinical visits. These infections can range from mild to life-threatening and include a severe subset known as Acute Bacterial Skin and Skin Structure Infections (ABSSSI). Prompt diagnosis and appropriate antibiotic use are crucial for optimizing patient outcomes while minimizing adverse effects and antimicrobial resistance. However, empirical treatment often becomes necessary due to the lack of culture specimens, making local epidemiology and clinical presentation key factors in treatment decisions. This expert opinion paper aims to outline the "golden rules" for the management of SSTIs in children, focusing on achieving microbiological clearance, clinical improvement, and effective control of symptoms, such as fever and pain, which significantly impact the child's well-being. These emphasize the principles of antimicrobial stewardship, recommending early diagnosis with appropriate laboratory tests, rational empiric therapy, and prompt switch to targeted therapy based on microbiological findings, as well as proper fever and pain management. The paper also highlights the importance of a multidisciplinary approach for complex cases, optimal dosing, and effective communication with patients' families to improve treatment compliance. Furthermore, antibiotic therapy should be selected to reduce hospital stay and facilitate home-based continuity of care, while follow-up and strengthening of the hospital-territory network are critical for continuity of care after discharge. These recommendations aim to optimize the management of pediatric SSTIs by ensuring comprehensive care from initial diagnosis to post-discharge follow-up, promoting the rational use of antibiotics, and ultimately improving clinical outcomes and quality of life for children and their families.
Keywords: Antimicrobial stewardship; Empirical therapy; Fever control; Pain management; Pediatric care; Skin and soft tissue infections.
© 2025. The Author(s).
Conflict of interest statement
Declarations. Ethics approval and consent to participate: Not applicable. Consent for publication: Not applicable. Competing interests: The authors participated in an Advisory Board supported by an unrestricted grant from Angelini Pharma. Furthermore, GPM received an unrestricted grant from Reckitt Benckiser Healthcare S.P.A. It is important to note that the sponsor had no role in the design, execution, interpretation or writing of this review.
Similar articles
-
Development and maintenance of consensus recommendations on pediatric outpatient antibiotic therapy in Germany: a framework for rational use.Eur J Pediatr. 2025 Jan 23;184(2):149. doi: 10.1007/s00431-024-05964-y. Eur J Pediatr. 2025. PMID: 39843792 Free PMC article.
-
Bacterial pathogens causing skin and soft tissue infections and antibiotic susceptibility in South Asia: a scoping review protocol.Syst Rev. 2025 Jul 4;14(1):136. doi: 10.1186/s13643-025-02885-1. Syst Rev. 2025. PMID: 40616178 Free PMC article.
-
Assessing the comparative effects of interventions in COPD: a tutorial on network meta-analysis for clinicians.Respir Res. 2024 Dec 21;25(1):438. doi: 10.1186/s12931-024-03056-x. Respir Res. 2024. PMID: 39709425 Free PMC article. Review.
-
[Bacterial skin and soft tissue infections].Klin Mikrobiol Infekc Lek. 2025 Jun;31(2):47-53. Klin Mikrobiol Infekc Lek. 2025. PMID: 40913414 Review. Czech.
-
A Comprehensive Analysis of Liposomal-Based Nanocarriers for Treating Skin and Soft Tissue Infection.Curr Drug Deliv. 2025;22(5):552-573. doi: 10.2174/0115672018328954240801110200. Curr Drug Deliv. 2025. PMID: 39136517 Review.
References
-
- Fritz SA, Shapiro DJ, Hersh AL. National Trends in Incidence of Purulent Skin and Soft Tissue Infections in Patients Presenting to Ambulatory and Emergency Department Settings, 2000–2015. Clin Infect Dis. 2020;70(12):2715–8. - PubMed
-
- Esposito S, Noviello S, Leone S. Epidemiology and microbiology of skin and soft tissue infections. Curr Opin Infect Dis. 2016;29(2):109–15. - PubMed
-
- Stevens DL, Bisno AL, Chambers HF, Dellinger EP, Goldstein EJ, Gorbach SL, et al. Practice guidelines for the diagnosis and management of skin and soft tissue infections: 2014 update by the Infectious Diseases Society of America. Clin Infect Dis. 2014;59(2):e47–59. - PubMed
-
- Galli L, Venturini E, Bassi A, Gattinara GC, Chiappini E, Defilippi C, et al. Common Community-acquired Bacterial Skin and Soft-tissue Infections in Children: an Intersociety Consensus on Impetigo, Abscess, and Cellulitis Treatment. Clin Ther. 2019;41(3):532-51.e17. - PubMed
-
- US Food and Drug Administration. Acute bacterial skin and skin structure infections: developing drugs for treatment Guidance for industry 2013. https://www.fda.gov/files/drugs/published/Acute-Bacterial-Skin-and-Skin-... Accessed 5 September 2024
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical